Hyaluronic acid-based nano drug delivery systems for breast cancer treatment: Recent advances
Breast cancer (BC) is the most common malignancy among females worldwide, and high resistance to drugs and metastasis rates are the leading causes of death in BC patients. Releasing anti-cancer drugs precisely to the tumor site can improve the efficacy and reduce the side effects on the body. Natura...
Main Authors: | Yufeng Jia, Siwen Chen, Chenyu Wang, Tao Sun, Liqun Yang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-08-01
|
Series: | Frontiers in Bioengineering and Biotechnology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fbioe.2022.990145/full |
Similar Items
-
Hyaluronic Acid-Based Nanocarriers for Anticancer Drug Delivery
by: Chao-Ping Fu, et al.
Published: (2023-05-01) -
Impacting the Remedial Potential of Nano Delivery-Based Flavonoids for Breast Cancer Treatment
by: Rakesh K. Sindhu, et al.
Published: (2021-08-01) -
Hyaluronic Acid Nanoparticles for Immunogenic Chemotherapy of Leukemia and T-Cell Lymphoma
by: Vinu Krishnan, et al.
Published: (2022-02-01) -
2-Chlorobenzoylthiourea-modified MCM-41 for Drug Delivery
by: Fatih Mehmet Emen, et al.
Published: (2019-05-01) -
A New Era in Ocular Therapeutics: Advanced Drug Delivery Systems for Uveitis and Neuro-Ophthalmologic Conditions
by: Kevin Y. Wu, et al.
Published: (2023-07-01)